Skip to main content
. Author manuscript; available in PMC: 2010 Feb 2.
Published in final edited form as: Invest Ophthalmol Vis Sci. 2007 Dec;48(12):5806. doi: 10.1167/iovs.07-0661

Table 1.

Treatment Characteristics and WFE Changes for the Centered Treatment (ΔW[x, y]) over 6- and 9-mm PDs

Centered Wavefront Error Change ΔW(x, y)
Eye Treatment (D) OZ (mm) TTZ (mm) PD (mm) Sphere(D) Cylinder (D) Axis (°) Total HOA RMS (μm) Coma RMS (μm) SA RMS (μm) rHOA RMS (μm)
c1-005 OD −6 8 11.1 9 +3.33 −0.58 172 2.412 1.019 1.838 1.184
6 +4.71 −0.61 12 0.541 0.197 0.333 0.388
c2-001 OS −6 6 9.1 9 +0.82 −0.37 91 1.790 0.516 1.585 0.650
6 +2.17 −0.65 88 0.618 0.285 0.327 0.440
c2-006 OS −6 6 9.1 9 +1.90 −0.11 79 1.155 0.324 0.991 0.496
6 +2.56 −0.24 40 0.307 0.120 0.039 0.280
c5-005 OD −10 6 9.1 9 +2.49 −0.28 29 2.182 0.414 2.108 0.381
6 +4.11 −0.28 37 0.574 0.296 0.426 0.246
c5-026 OD −10 6 9.1 9 +3.24 −0.45 174 2.983 0.423 2.924 0.409
6 +5.29 −0.47 160 0.430 0.291 0.262 0.178

OZ, diameter of the programmed optical zone; TTZ, diameter of the total treatment zone; total HOA RMS, root mean square value of 3rd- to 10th-order aberrations; coma RMS, RMS value of 3rd- to 9th-order coma; SA RMS, RMS value of 4th- to 10th-order spherical aberration; rHOA RMS, residual RMS of all noncoma, nonspherical HOA.